Targeting Residual Disease in Oncogene-Driven NSCLC

被引：0
|
作者：
McCoach, C. E. [1 ]
Merrick, D. T. [1 ]
Aisner, D. L. [1 ]
Bunn, P. A. [1 ]
Camdige, D. R. [1 ]
Heasley, L. E. [1 ]
Doebele, R. C. [1 ]
机构：
[1] Univ Colorado, Ctr Canc, Denver, CO 80262 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 08期
关键词：
D O I：
10.1016/j.jtho.2017.06.064
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S1546 / S1546
页数：1
相关论文
共 50 条
  • [1] A framework for understanding and targeting residual disease in oncogene-driven solid cancers
    Trever G Bivona
    Robert C Doebele
    [J]. Nature Medicine, 2016, 22 : 472 - 478
  • [2] A framework for understanding and targeting residual disease in oncogene-driven solid cancers
    Bivona, Trever G.
    Doebele, Robert C.
    [J]. NATURE MEDICINE, 2016, 22 (05) : 472 - 478
  • [3] Systemic Therapy for Advanced Oncogene-Driven NSCLC
    Gandara, David R.
    Popat, Sanjay
    Melosky, Barbara
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S51 - S52
  • [4] Perioperative targeted therapy for oncogene-driven NSCLC
    Liu, Si -Yang
    Zhang, Jia-Tao
    Zeng, Kang-Hui
    Wu, Yi-Long
    [J]. LUNG CANCER, 2022, 172 : 160 - 169
  • [5] Overcoming MET-mediated resistance in oncogene-driven NSCLC
    Reischmann, Nadine
    Schmelas, Carolin
    Molina-Vila, Miguel Angel
    Jordana-Ariza, Nuria
    Kuntze, Daniel
    Garcia-Roman, Silvia
    Simard, Manon A.
    Musch, Doreen
    Esdar, Christina
    Albers, Joachim
    Karachaliou, Niki
    [J]. ISCIENCE, 2023, 26 (07)
  • [6] TYROSINE KINASE INHIBITORS AS A TREATMENT OF SYMPTOMATIC CNS METASTASES IN ONCOGENE-DRIVEN NSCLC
    Benouaich-Amiel, Alexandra
    Gal, Omer
    Dudnik, Elizabeth
    Rotem, Ofer
    Finket, Inbar
    Peretz, Idit
    Zer, Alona
    Mandel, Jacob
    Siegal, Tali
    Bar, Jair
    Yust-Katz, Shlomit
    [J]. NEURO-ONCOLOGY, 2020, 22 : 1 - 1
  • [7] Are Immune Checkpoint Inhibitors Effective Against Uncommon Oncogene-Driven NSCLC Subtypes?
    Eguren-Santamaria, Inaki
    Sanmamed, Miguel F.
    Gil-Bazo, Ignacio
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (04) : 489 - 492
  • [8] Tyrosine Kinase Inhibitors as a Treatment of Symptomatic CNS Metastases in Oncogene-Driven NSCLC
    Gal, Omer
    Dudnik, Elizabeth
    Rotem, Ofer
    Finkel, Inbar
    Peretz, Idit
    Zer, Alona
    Mandel, Jacob
    Amiel, Alexandra
    Siegal, Tali
    Bar, Jair
    Lobachov, Anastasiya
    Yust, Shlomit
    [J]. JOURNAL OF ONCOLOGY, 2020, 2020
  • [9] Oncogene-Driven Metabolic Alterations in Cancer
    Min, Hye-Young
    Lee, Ho-Young
    [J]. BIOMOLECULES & THERAPEUTICS, 2018, 26 (01) : 45 - 56
  • [10] Inflammation and cancer: The oncogene-driven connection
    Borrello, Maria Grazia
    Degl'Innocenti, Debora
    Pierotti, Marco A.
    [J]. CANCER LETTERS, 2008, 267 (02) : 262 - 270
12345